I. Heider et Dopaminergic neurotoxicity of homocysteine and its derivatives in primary mesencephalic cultures.- D. Woitalla et MTHFR C 677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease.- A. S. Glass et Screening for mutations in synaptotagmin XI in Parkinson's disease.- A. Heinz et Depletion and restoration of endogenous monoamines affects ß-CIT binding to serotonin but not dopamine transporters in non-human primates.- J. Uekermann et Differential executive control impairments in early Parkinson's disease.- S. Muhlack et Simple movement sequences better correlate to levodopa plasma levels than complex ones.- Ch. Börnke et Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.- G. Schmid et Impact of apomorphine on BOLD signal during movement in normals.- Th. Müller et Worsened motor test performance following acute apomorphine injection in previously untreated patients with Parkinson's disease.- D. Woitalla et Transdermal lisuride delivery in the treatment of Parkinson's disease.- C. Saft, C. et Congruent deterioration of complex and simple movements in patients with Huntington's disease.- N. Brune et Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.- J. Andrich et Coenzyme Q10 serum levels in Huntington's Disease.- A. Beister et The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease.- Th. Postert et Transcranial sonography in spinocerebellar ataxia type 3.- L. Schöls et Therapeutic strategies in Friedreich's ataxia.- V. G. Hösing et Cholecystokinin- and cholecystokinin-B-receptor gene polymorphgisms in panic disorder